These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3003728)

  • 21. Enalapril in congestive heart failure: acute hemodynamic and neurohumoral evaluation and short-term follow-up.
    Lin M; Chiang HT; Chang MS; Kong CW; Wang SP; Chiang BN
    Zhonghua Yi Xue Za Zhi (Taipei); 1991 Jul; 48(1):31-40. PubMed ID: 1679372
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of enalapril maleate on survival of dogs with naturally acquired heart failure. The Long-Term Investigation of Veterinary Enalapril (LIVE) Study Group.
    Ettinger SJ; Benitz AM; Ericsson GF; Cifelli S; Jernigan AD; Longhofer SL; Trimboli W; Hanson PD
    J Am Vet Med Assoc; 1998 Dec; 213(11):1573-7. PubMed ID: 9838955
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute haemodynamic, hormonal and electrolyte effects and short-term clinical response to enalapril in heart failure.
    Fitzpatrick D; Nicholls MG; Ikram H; Espiner EA
    J Hypertens Suppl; 1983 Oct; 1(1):147-53. PubMed ID: 6100604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness of converting enzyme inhibition (enalapril) for mild congestive heart failure.
    Kromer EP; Riegger GA; Liebau G; Kochsiek K
    Am J Cardiol; 1986 Feb; 57(6):459-62. PubMed ID: 3004187
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in beta-adrenoceptors in heart failure due to myocardial infarction are attenuated by blockade of renin-angiotensin system.
    Sethi R; Shao Q; Ren B; Saini HK; Takeda N; Dhalla NS
    Mol Cell Biochem; 2004 Aug; 263(1-2):11-20. PubMed ID: 15524163
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [What have we learned about inhibitors of the renin-angiotensin system?].
    Waeber B; Nussberger J; Brunner HR
    Ann Endocrinol (Paris); 1986; 47(3):167-77. PubMed ID: 3022638
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sustained haemodynamic effects of enalapril in left ventricular failure.
    Kjekshus JK; Søyland E; Dickstein K; Abrahamsen AM; Gundersen T
    J Hypertens Suppl; 1983 Oct; 1(1):143-5. PubMed ID: 6100603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Haemodynamic, hormonal, and electrolyte effects of enalapril in heart failure.
    Fitzpatrick D; Nicholls MG; Ikram H; Espiner EA
    Br Heart J; 1983 Aug; 50(2):163-9. PubMed ID: 6309203
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angiotensin-converting enzyme inhibition restores the diffusing capacity for carbon monoxide in patients with chronic heart failure by improving the molecular diffusion across the alveolar capillary membrane.
    Guazzi M; Agostoni P
    Clin Sci (Lond); 1999 Jan; 96(1):17-22. PubMed ID: 9857102
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of enalapril, a new angiotensin-converting enzyme inhibitor, in a controlled trial in heart failure.
    Franciosa JA; Wilen MM; Jordan RA
    J Am Coll Cardiol; 1985 Jan; 5(1):101-7. PubMed ID: 2981088
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immediate converting-enzyme inhibition with intravenous enalapril in chronic congestive heart failure.
    Kubo SH; Cody RJ; Laragh JH; Prida XE; Atlas SA; Yuan Z; Sealey JE
    Am J Cardiol; 1985 Jan; 55(1):122-6. PubMed ID: 2981462
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enalapril: a new angiotensin-converting enzyme inhibitor in chronic heart failure: acute and chronic hemodynamic evaluations.
    DiCarlo L; Chatterjee K; Parmley WW; Swedberg K; Atherton B; Curran D; Cucci M
    J Am Coll Cardiol; 1983 Nov; 2(5):865-71. PubMed ID: 6313787
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Both enalapril and losartan attenuate sarcolemmal Na+-K+-ATPase remodeling in failing rat heart due to myocardial infarction.
    Guo X; Wang J; Elimban V; Dhalla NS
    Can J Physiol Pharmacol; 2008 Apr; 86(4):139-47. PubMed ID: 18418421
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contrasting renal haemodynamic responses to the angiotensin converting enzyme inhibitor enalapril and the beta-adrenergic antagonist metoprolol in essential hypertension.
    O'Connor DT; Mosley CA; Cervenka J; Bernstein KN
    J Hypertens Suppl; 1984 Dec; 2(2):S89-92. PubMed ID: 6100882
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of long-term treatment with enalapril or hydralazine on the renin-angiotensin-aldosterone system and fluid balance in dogs with naturally acquired mitral valve regurgitation.
    Häggström J; Hansson K; Karlberg BE; Kvart C; Madej A; Olsson K
    Am J Vet Res; 1996 Nov; 57(11):1645-52. PubMed ID: 8915446
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute and short-term hemodynamic, echocardiographic, and clinical effects of enalapril maleate in dogs with naturally acquired heart failure: results of the Invasive Multicenter PROspective Veterinary Evaluation of Enalapril study. The IMPROVE Study Group.
    J Vet Intern Med; 1995; 9(4):234-42. PubMed ID: 8523320
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overview: the role of angiotensin-converting enzyme inhibitors in cardiovascular therapy.
    Abrams WB; Davies RO; Ferguson RK
    Fed Proc; 1984 Apr; 43(5):1314-21. PubMed ID: 6323221
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of a reduction in haemoglobin concentration by enalapril in stable, moderate heart failure: a double blind study.
    Herrlin B; Nyquist O; Sylvén C
    Br Heart J; 1991 Sep; 66(3):199-205. PubMed ID: 1931347
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Usefulness of plasma renin activity in predicting haemodynamic and clinical responses and survival during long term converting enzyme inhibition in severe chronic heart failure. Experience in 100 consecutive patients.
    Packer M; Medina N; Yushak M; Lee WH
    Br Heart J; 1985 Sep; 54(3):298-304. PubMed ID: 2994697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.